Iiekking G Doug

Avg. Two Year Performance

No purchase track record
(7%) Avg. Sale Return
(3%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return2%(4%)2%(3%)(7%)
Sale Success Rate5 of 152 of 156 of 154 of 156 of 15

USANA Health Sciences Inc.

Drugs » Drug Related Products

CHIEF FINANCIAL OFFICER:

Holdings: 5.2K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--